Highlights
NASDAQ: INVA       Innoviva Inc
Last Price Today's Change   Day's Range   Trading Volume
13.745   -0.175 (1.26%)  13.62 - 14.11  84,143

Overview

 
Avg Volume (4 weeks):756,968
4 Weeks Range:13.04 - 14.89
4 Weeks Price Volatility (%):
38.11%
52 Weeks Range:7.58 - 15.35
52 Weeks Price Volatility (%):
79.34%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes RELVAR/BREO/ELLIPTA, ANORO, ELLIPTA, TRELEGY, ELLIPTA, and others. The firm collaborates with and receives funding from GlaxoSmithKline.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3487  2132  456  2880 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CIDM 3.99+2.68 
 VISL 0.858+0.433 
 GNUS 8.04+0.11 
 XSPA 1.84+0.76 
 AVP 5.60-0.05 
 AAL 13.935+2.085 
 NIO 5.875+0.275 
 AABA 19.630.00 
 TGE 22.39+0.81 
 SAVE 20.32+3.01 
Partners & Brokers